Like Cornerstone Research Group

announced 10/30/2019 via Company Press Release

Eversana, will acquire Cornerstone Research Group

synopsis: EVERSANA™, the leading independent provider of commercial services to the life science industry, announced an agreement to acquire Canada-based Cornerstone Research Group, Inc. Cornerstone is a global health economic and market access research company supporting pharmaceutical and medical device companies.
buyer parent: Water Street Healthcare Partners
buyer: Eversana
EVERSANA offers a fully integrated and independent commercial services platform designed to solve global pricing, access, reimbursement, adherence and product delivery challenges in the life science sector. "
target: Cornerstone Research Group
Cornerstone is a global health economic and market access research company supporting pharmaceutical and medical device companies. Founded in 2005, Cornerstone’s initial focus was to build on the partners’ experience in health economic research with an emphasis on global cost-effectiveness models.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/4/2015 via PR Newswire

Precision for Value, acquired Redwood Outcomes

synopsis: Precision for Value, a company that supports commercial excellence for global pharmaceutical and life sciences clients through the demonstration and communication of product value and outcomes, announced its acquisition of Redwood Outcomes, a leading international health economics and outcomes research company.
buyer parent: Precision for Medicine
buyer: Precision for Value
Precision for Value supports excellence for global pharmaceutical and life sciences clients through the communication of product value and outcomes. The Precision for Value teams provide clients with services of industry knowledge, demonstrated analytics proficiency, and communications prowess. "
target: Redwood Outcomes
Redwood Outcomes is a Health Economics & Outcomes Research firm. They aim to advance and apply the science of evidence synthesis, integration, and communication to optimize health care decision-making.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/19/2011 via Company Press Release

ICON Plc, acquired Oxford Outcomes

synopsis: ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, has announced the expansion of its Late Phase and Outcomes Research services through the acquisition of Oxford Outcomes, a leading international health outcomes consultancy.
buyer: ICON Plc (ICLR:$1,541.91)
ICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. "
target: Oxford Outcomes
Headquartered in Oxford, UK, and with offices in the USA and Canada, Oxford Outcomes provides specialist services in the areas of patient reported outcomes (PRO), health economics, epidemiology and translation and linguistic validation.
price ($mm)
$28*
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/16/2021 via Company Press Release

Sermo, acquired Minter Group

synopsis: Sermo, the world’s leading healthcare provider insights company and the first social media platform for physicians, announced its acquisition of Australia-based market research leader, Minter Group. Since 2003 Minter has built a variety of research panels across various industries including IT, consumer and healthcare.
buyer: Sermo
Sermo is the world’s leading healthcare provider insights company and the first social media platform for physicians. They offer a unique physician-first online community that allows clinicians to communicate about issues that are important to them and their patients. "
target: Minter Group
Minter Group is an Australia-based market research leader. Since 2003 Minter has built a variety of research panels across various industries including IT, consumer and healthcare.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/25/2020 via BusinessWire

W2O Group, acquired Elysia Group

synopsis: W2O, the leading independent provider of analytics-driven, technology-enabled marketing and communications solutions to the healthcare sector, announced it has acquired Elysia Group, a health economic and outcomes research (HEOR) consulting firm operating in the United States and Asia Pacific.
buyer parent: New Mountain Capital, LLC
buyer: W2O Group
W2O is an independent provider of analytics-driven, digital-first marketing and communications to the healthcare sector. W2O applies analytics models, methodologies and approaches in a digital world to design precise communications and marketing strategies to deliver sustained business results. "
target: Elysia Group
Elysia Group is a health economic and outcomes research consulting firm. Elysia provides pharmaceutical and medical device clients with innovative modeling approaches to health economic strategy and evidence development using data and analytics and real-world evidence.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/25/2012 via PR Newswire

McCann Health, acquired Double Helix

synopsis: McCann Health announced the acquisition of Double Helix. Double Helix is a leading, global provider of Market Research and Market Access services to the pharmaceutical and medical device industries. Dr. Wayne Phillips, who founded and runs Double Helix, will continue as CEO of Double Helix, reporting to John Cahill, CEO of McCann Health.
buyer parent: Interpublic Group of Companies, Inc.
buyer: McCann Health
Comprising the world's most connected health and wellness experts, McCann Health is the most awarded professional and consumer health communications network with the largest international expertise spanning 35 countries and 61 offices. "
target: Double Helix
Double Helix is an independent healthcare consultancy with headquarters in London and offices in the US and Singapore. Established in 1995, they have been providing pharmaceutical, biotech and medical device clients of all sizes with the knowledge to evolve their brands and businesses.
price ($mm)
$55
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/14/2009 via BusinessWire

Majestic Research, LLC, acquired Rood Research, Inc.

synopsis: Majestic Research, a global, independent equity research company and a pioneer in data driven analysis, announced its acquisition of New York-based Rood Research – a leading provider of healthcare market research.
buyer: Majestic Research, LLC
Since its inception in 2002, Majestic Research has revolutionized the financial research business with our innovative proprietary methods and tools for accessing real-time data. "
target: Rood Research, Inc.
In the past 15 years, Rood Research has become a leader in providing healthcare research to some of the top pharmaceutical and biotech companies in the world.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/30/2008 via BusinessWire

Surveillance Data, Inc., acquired Verispan, LLC

synopsis: SDI, the leader in innovative healthcare analytics, has acquired Verispan, a top provider of healthcare information and services. The acquisition creates the healthcare industry’s most comprehensive de-identified longitudinal database.
buyer parent: LLR Partners
buyer: Surveillance Data, Inc.
SDI provides a wide range of healthcare data and market research to pharmaceutical, consumer products, and healthcare-related companies. Since 1981, SDI's mission has been to provide healthcare data products with high business relevance as well as the means and know-how to put this data into action."
target: Verispan, LLC
Verispan provides a broad array of information products and services to virtually all of the top 50 pharmaceutical companies and the healthcare industry in general, including sales targeting and compensation products; market research audits; healthcare profiles; and direct mail, among many others.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/15/2017 via BusinessWire

TractManager, acquired HAYES, Inc.

synopsis: TractManager, Inc., the healthcare industry’s largest supplier of strategic sourcing and contract lifecycle management (CLM) solutions, has acquired Hayes, Inc., an industry leader in providing clinically focused, evidence-based research and analysis to health plans, insurers, hospitals, healthcare systems, ACOs, and government agencies.
buyer parent: Arsenal Capital Partners
buyer: TractManager
TractManager’s healthcare-specific application suite serves three out of five U.S. hospitals. Serving the healthcare industry with integrity for more than 30 years, TractManager is the first-mover in strategic sourcing and enterprise contract lifecycle management. "
target: HAYES, Inc.
Hayes, Inc. is an industry leader in providing clinically focused, evidence-based research and analysis to health plans, insurers, hospitals, healthcare systems, ACOs, and government agencies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/17/2006 via PR Newswire

United BioSource Corporation, acquired MetaWorks, Inc.

synopsis: United BioSource Corporation (UBC) today announced the acquisition of MetaWorks, Inc., a leading provider of systematic reviews and meta-analyses to inform development, marketing, and regulatory decision-making regarding health care products and services.
buyer: United BioSource Corporation
United BioSource Corporation accelerates the generation, analysis and communication of real world evidence by integrating scientific and operational expertise with innovative technology solutions to support global development and commercialization of medical products for life science companies. "
target: MetaWorks, Inc.
MetaWorks Inc. has gained a reputation as one of the healthcare industry's most expert and reliable sources for Evidence-Based Medical Information and technology. MetaWorks is a leading provider of systematic reviews, meta-analyses and other evidence-based-information services.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/4/2019 via BusinessWire

Pharmerit International merged with Open Health,

synopsis: OPEN Health, a leading multi-disciplinary health communications and market access group, has merged with Pharmerit International, LP, the largest independent global provider of health economics and outcomes research and strategic market access services to the pharmaceutical industry.
buyer parent: Amulet Capital Partners LP
buyer: Open Health
OPEN Health is a multi-disciplinary health communications and market access group, operating across three core business areas: Medical Communications; Patient and Brand Communications; and Value, Informatics and Evidence. "
target: Pharmerit International
Pharmerit International is a global, premier health economics and outcomes research (HEOR) consultancy with 20 years of experience supporting pharmaceutical, biotechnology, and medical device organizations in HEOR and market access worldwide.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/13/2021 via Company Press Release

Research America, Inc., acquired xsperient

synopsis: Research America, Inc., the top marketing research firm located outside Philadelphia, has acquired xsperient, a prominent market research company in the field of applying the behavioral sciences to healthcare and wellness consulting, market research, and market segmentation.
buyer: Research America, Inc.
Research America is a full-service market research and consumer insights company. The company uses a consultative approach that leverages its diverse experience and innovative data-driven tools that produce results. "
target: xsperient
xsperient is a full-service market research company using advanced techniques for qualitative and quantitative studies. They apply the measurable science of psychology and sophisticated mathematical modeling techniques to healthcare and wellness market research and market segmentation.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 3/8/2012 via PR Newswire

Diversified Agency Services, will acquire Medical Collective Intelligence Co. Ltd.

synopsis: Diversified Agency Services announced an agreement with ITOCHU Corporation and a number of venture capital funds to acquire a majority stake in Medical Collective Intelligence Co. Ltd., a highly respected Japanese online medical communications agency.
buyer parent: Omnicom Group Inc.
buyer: Diversified Agency Services
Diversified Agency Services (DAS), a division of Omnicom Group Inc., manages Omnicom's holdings in a variety of marketing disciplines. DAS includes more than 190 companies, which operate through a combination of networks and regional organizations. "
target parent: Itochu Corporation
target: Medical Collective Intelligence Co. Ltd.
Medical Collective Intelligence Co. Ltd. ("MCI") is a highly respected and well-known Japanese online medical communications agency. Based in Tokyo, MCI operates a Marketing Research division and a Detailing Solutions division, both focused on the healthcare industry.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/9/2009 via BusinessWire

IntrinsiQ, acquired WWMR, Inc.

synopsis: IntrinsiQ, the company improving the quality and understanding of cancer care, announced the acquisition of market research and consulting firm WWMR, Inc. The combination creates the single, go-to source for pharmaceutical companies seeking to understand the true drivers behind physicians’ cancer treatment decisions.
buyer parent: Kohlberg Kravis Roberts & Co.
buyer: IntrinsiQ
IntrinsiQ, LLC is the leading provider of medical oncology clinical information systems and the premier source of US oncology data and analysis. Each month, IntrinsiQ’s clinical software application, IntelliDose®, captures the treatment decisions and details for nearly 20,000 unique patients. "
target: WWMR, Inc.
WWMR is a marketing research and strategic consulting firm founded in 1994, providing insightful, proprietary studies to pharmaceutical, biotech, medical device, and diagnostics companies worldwide.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/17/2017 via GlobeNewswire

TelaDoc, Inc., acquired Best Doctors, Inc.

synopsis: Teladoc, Inc., the nation’s first and largest telehealth platform, announced the completion of its acquisition of Best Doctors, the world’s leading expert medical consultation company focused on improving health outcomes for the most complex, critical and costly medical issues.
buyer: TelaDoc, Inc. (TDOC:$716.29)
Teladoc, Inc. is the nation’s first and largest telehealth platform. Recognized by MIT Technology Review as one of the “50 Smartest Companies,” Teladoc is forging a new healthcare experience with an innovative portfolio of virtual care delivery solutions. "
target: Best Doctors, Inc.
Best Doctors is the world’s leading medical consultation company that connects individuals facing difficult diagnostic or medical treatment decisions with the best doctors, ranked by impartial peer review in over 450 subspecialties of medicine, to review their diagnosis and treatment plans.
price ($mm)
$440
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/1/2021 via GlobeNewswire

Cerner Corporation, acquired Kantar Health

synopsis: Cerner Corporation, a global health care technology company, has acquired Kantar Health, a division of Kantar Group. Kantar Health is a leading data, analytics and real-world evidence and commercial research consultancy serving the life science industry.
buyer: Cerner Corporation (CERN:$5,707.53)
Cerner’s health technologies connect people and information systems at thousands of contracted provider facilities worldwide dedicated to creating smarter and better care for individuals and communities. "
target parent: Bain Capital
target: Kantar Health
Kantar Health SA provides healthcare consulting and marketing research services. The company was formerly known as Taylor Nelson Sofres Healthcare SA. The company is based in Madrid, Spain. Kantar Health SA operates as a subsidiary of WPP plc.
price ($mm)
$375
rev ($mm)
$150
EBITDA ($mm)
EV / rev
2.5x
EV / EBITDA
closed 3/19/2020 via BNC Analysis

M3 USA Corporation, purchased Healthcare Market Research Business from Manthan Systems

synopsis: M3 Global Research announced the acquisition of Manthan's healthcare market research business. India-based Manthan is a cloud analytics company pioneering applications for retail and consumer-facing businesses. Its healthcare division will be rebranded after the acquisition as m360 Research.
buyer parent: M3, Inc.
buyer: M3 USA Corporation
M3 USA (M3 Global Research), named to represent Medicine, Media, and Metamorphosis, was founded to change the world of medicine through full use of the power of the Internet. M3 provides the life science industry with highly targeted interactive marketing, education, content, and research solutions."
seller: Manthan Systems
The acquisition includes the healthcare market research business of Manthan. India-based Manthan is a cloud analytics company pioneering applications for retail and consumer-facing businesses. Its healthcare division will be rebranded after the acquisition as m360 Research.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/1/2011 via BNC Analysis

IMS Health Incorporated, acquired SDI Health LLC

synopsis: IMS Health has completed its acquisition of SDI, a leading healthcare market insight and analytics firm. It provides the industry’s most comprehensive de-identified patient-level data to pharmaceutical, biotech, and medical device companies, enabling them to better understand the healthcare market.
buyer parent: TPG Capital
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries. IMS offers leading-edge market intelligence products and services that are integral to clients’ day-to-day operations. "
target parent: LLR Partners
target: SDI Health LLC
SDI is a leading healthcare market insight and analytics firm. It provides the industry’s most comprehensive de-identified patient-level data to pharmaceutical, biotech, and medical device companies, enabling them to better understand the healthcare market.
price ($mm)
$340
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 11/22/2010 via BusinessWire

M3 USA Corporation, will acquire EMS Research

synopsis: M3 USA, parent company of MDLinx, a leading medical market research firm, has signed an agreement to purchase EU-based EMS Research, a company specializing in quantitative and qualitative market research for clients in healthcare and other vertical markets.
buyer parent: Sony Corporation
buyer: M3 USA Corporation
M3 USA, named to represent Medicine, Media, and Metamorphosis, was founded with the goal of changing the world of medicine through full use of the power of the Internet. M3 provides the life science industry with highly targeted interactive marketing, education, content, and research solutions. "
target: EMS Research
EMS Research (European Marketing Specialists), headquartered in London, England, was founded in 1999 and is Europe’s leading in-house medical fieldwork company. EMS help clients achieve their objectives by delivering vital insight into markets, attitudes, concepts and products.
price ($mm)
rev ($mm)
$6
EBITDA ($mm)
EV / rev
0.0x
EV / EBITDA
closed 11/13/2007 via PR Newswire

Cegedim Group S.A., acquired 3ES

synopsis: Cegedim Strategic Data, leading provider of Pharmaceutical Market Research has completed its acquisition of 3ES, a CRO member of the AFCRO, specializing in Clinical Studies and post-AMM studies, notably through online tools.
buyer: Cegedim Group S.A. (ENXTPA:CGM:$592.02)
Established as the world's leading CRM provider for the life sciences industry with its Cegedim Dendrite business unit, CEGEDIM provides the world's largest pharmaceutical companies with vital support for successful Customer Relationship Management (CRM). "
target: 3ES
3ES provides multidisciplinary expertise in the medical research field. 3ES has developed their in-house software for managing online studies via Internet, and has received the ANVAR label for "innovating business".
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 10/30/2019 via Company Press Release

Eversana, will acquire Cornerstone Research Group

synopsis: EVERSANA™, the leading independent provider of commercial services to the life science industry, announced an agreement to acquire Canada-based Cornerstone Research Group, Inc. Cornerstone is a global health economic and market access research company supporting pharmaceutical and medical device companies.
buyer parent: Water Street Healthcare Partners
buyer: Eversana
EVERSANA offers a fully integrated and independent commercial services platform designed to solve global pricing, access, reimbursement, adherence and product delivery challenges in the life science sector. "
target: Cornerstone Research Group
Cornerstone is a global health economic and market access research company supporting pharmaceutical and medical device companies. Founded in 2005, Cornerstone’s initial focus was to build on the partners’ experience in health economic research with an emphasis on global cost-effectiveness models.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 10/20/2021 via PR Newswire

Eversana, will acquire Intouch Group, LLC

synopsis: EVERSANA, the pioneer of next generation commercial services to the global life sciences industry, will acquire Intouch Group, a full-service global agency network serving the pharmaceutical industry. Together, the combined companies are poised to deliver full-scale commercialization to pharmaceutical companies globally.
buyer parent: Water Street Healthcare Partners
buyer: Eversana
EVERSANA is the leading provider of global services to the life sciences industry. The company's integrated solutions are rooted in the patient experience and span all stages of the product life cycle to deliver long-term, sustainable value for patients, prescribers, channel partners and payers. "
target: Intouch Group, LLC
Intouch Group is a privately held full-service agency network, providing creative and media services, enterprise solutions and data analytics globally through nine affiliates in eight offices, including Intouch Solutions, Intouch Proto, Intouch Seven, Intouch International, and Intouch Media.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/9/2020 via BNC Analysis

Eversana, acquired Alkemy Partners LLC

synopsis: EVERSANA™, the leading provider of commercial services to the life science industry, announced the acquisition of Alkemy Partners, a full-service field learning and development company committed to solving market access, sales and clinical engagement through training, content creation and digital solutions.
buyer parent: Water Street Healthcare Partners
buyer: Eversana
EVERSANA offers a fully integrated and independent commercial services platform designed to solve global pricing, access, reimbursement, adherence and product delivery challenges in the life science sector. "
target: Alkemy Partners LLC
Alkemy Partners is a full-service field learning and development company committed to solving market access, sales and clinical engagement through training, content creation and digital solutions.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/15/2020 via PR Newswire

Eversana, acquired HVH Precision Analytics

synopsis: EVERSANA™, the leading provider of commercial services to the life science industry, announced the acquisition of HVH Precision Analytics and its predictive analytics platform. Previously owned by Havas Health & You and Perspecta, HVH's Artificial Intelligence (AI) and machine learning platform has been refined to transform the healthcare sector.
buyer parent: Water Street Healthcare Partners
buyer: Eversana
EVERSANA offers a fully integrated and independent commercial services platform designed to solve global pricing, access, reimbursement, adherence and product delivery challenges in the life science sector. "
target parent: Vivendi SA
target: HVH Precision Analytics
HVH Precision Analytics and its predictive analytics platform leverage analytic expertise originally honed to support military and U.S. intelligence community. HVH's Artificial Intelligence (AI) and machine learning platform has been refined to transform the healthcare sector.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 10/30/2019 via Company Press Release

Eversana, will acquire Cornerstone Research Group

synopsis: EVERSANA™, the leading independent provider of commercial services to the life science industry, announced an agreement to acquire Canada-based Cornerstone Research Group, Inc. Cornerstone is a global health economic and market access research company supporting pharmaceutical and medical device companies.
buyer parent: Water Street Healthcare Partners
buyer: Eversana
EVERSANA offers a fully integrated and independent commercial services platform designed to solve global pricing, access, reimbursement, adherence and product delivery challenges in the life science sector. "
target: Cornerstone Research Group
Cornerstone is a global health economic and market access research company supporting pharmaceutical and medical device companies. Founded in 2005, Cornerstone’s initial focus was to build on the partners’ experience in health economic research with an emphasis on global cost-effectiveness models.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/9/2020 via BusinessWire

The Clarke Companies, acquired Covex, LLC

synopsis: The Clarke Companies, a leading provider of packaging, automation, validation and vision inspection services to the Life Sciences Industry, has acquired Covex, LLC, the premier global provider of validation, compliance, engineering and IT services for the Pharmaceutical, Life Sciences, and Chemical industries.
buyer: The Clarke Companies
The Clarke Companies is a leading provider of packaging, automation, validation and vision inspection services to the Life Sciences Industry. The Clarke Companies include Clarke Solutions and Acquire Automation. "
target: Covex, LLC
Covex, LLC is the premier global provider of validation and compliance services for the Pharmaceutical, Life Sciences, and Chemical industries. Covex Systems Validation, Regulatory Compliance, Engineering and IT Services offer an end-to-end solution for their clients.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/27/2018 via Company Press Release

The WIRB-Copernicus Group, acquired ACI Clinical

synopsis: WIRB-Copernicus Group, the world’s leading provider of solutions that measurably improve the quality and efficiency of clinical research, has acquired ACI Clinical, a specialty provider of clinical trial committees and clinical trial advisory services.
buyer parent: Arsenal Capital Partners
buyer: The WIRB-Copernicus Group
WIRB-Copernicus Group (WCG) is the world's leading provider of solutions to measurably improve the quality and efficiency of clinical research. WCG enables biopharmaceutical companies, CROs and institutions to accelerate the delivery of new treatments and therapies to patients. "
target: ACI Clinical
ACI Clinical is a specialty provider of clinical trial committees and clinical trial advisory services. ACI Clinical specializes in clinical and safety consulting, including full service Endpoint Adjudication Committees and Data Monitoring Committees.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/15/2014 via BNC Analysis

Synchrogenix Information Strategies, Inc. merged with Certara,

synopsis: Arsenal Capital Partners have acquired Synchrogenix Information Strategies Inc., which will merge with Certara LP. Synchrogenix, a specialty contract research organization providing strategic regulatory writing and related services to pharmaceutical, biotechnology, and medical device companies worldwide.
buyer parent: Arsenal Capital Partners
buyer: Certara (:$261.77)
Certara™ is dedicated to improving human health through a broad spectrum of software products and services, from molecular discovery through clinical development, with special focus on supporting translational approaches to drug development. "
target: Synchrogenix Information Strategies, Inc.
Synchrogenix is a specialty contract research organization providing strategic regulatory writing and related services to pharmaceutical, biotechnology, and medical device companies worldwide. The company offers pre-clinical, clinical, CMC, and drug safety writing and submission services.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 12/4/2013 via PR Newswire

Accelera Innovations, Inc., will acquire Behavioral Health Care Associates, Ltd.

synopsis: Accelera Innovations, Inc., a provider of cloud based software-as-a-service solutions to the healthcare industry announced that they have signed a stock purchase agreement to acquire 100% of Behavioral Health Care Associates, Ltd., a provider of billing, practice management and administrative services to doctors and other clinicians.
buyer: Accelera Innovations, Inc.
Accelera Innovations, Inc. offers cloud based software-as-a-service solutions to the healthcare industry that includes technology and services to providers and payers, who are seeking to create an interoperable technology platform that is patient-centric. "
target: Behavioral Health Care Associates, Ltd.
Behavioral Health Care Associates, Ltd. provides billing, practice management and administrative services to doctors and other clinicians who provide services to hospitals, nursing homes and individual clients.
price ($mm)
$4.55
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/21/2013 via BNC Analysis

DrugDev, acquired CFS Clinical

synopsis: DrugDev, an interactive network and data sharing platform for over 80,000 clinical trial doctors in 93 countries, announced its acquisition of CFS Clinical (CFS), the leading specialty provider focused on the business and financial management activities for clinical trials.
buyer: DrugDev
DrugDev helps the clinical trials industry run faster, cheaper and smarter trials. Experienced Investigators choose to be part of the free network to access new clinical trial opportunities they would not otherwise have learnt about. "
target: CFS Clinical
CFS Clinical (CFS) is a technology-enabled service provider focused on the business and financial management activities for clinical trials.CFS’ experts deliver best-in-class Investigator site payment and study startup solutions around the globe.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/20/2012 via PR Newswire

ePharmaSolutions, Inc., acquired Polaris Biopharma Consulting

synopsis: ePharmaSolutions announced the acquisition of Polaris BioPharma Consulting, a leading global patient recruitment and retention firm headquartered in Slough, UK. Polaris Biopharma was founded in 1999 as a boutique patient recruitment and retention firm supporting global pharmaceutical companies.
buyer: ePharmaSolutions, Inc.
ePharmaSolutions is a leading provider of technology-based clinical services that helps improve the way sites are selected, trained, activated and managed to exceed enrollment goals. ePharmaSolutions won the 2009 Bio-IT World Award for best clinical trial technology. "
target: Polaris Biopharma Consulting
Polaris Biopharma Consulting is a boutique patient recruitment and retention firm. Polaris has helped large and mid-sized pharmaceutical companies and CROs develop and deploy hundreds of global feasibility, trial optimisation and patient recruitment programs in every major therapeutic area.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/13/2006 via BusinessWire

Applied Clinical Intelligence merged with TAKE Solutions, Inc.,

synopsis: TAKE Solutions, Inc. announced the formation of the OneClinical brand of life sciences offerings as part of its merger with Applied Clinical Intelligence and OnSphere Corporation. OneClinical combines a full spectrum of proven data and document management software products and services for clinical trials, drug and device development lifecycles.
buyer parent: Shriram Group
buyer: TAKE Solutions, Inc. (BSE:532890:$259.76)
TAKE Solutions is a leading international business technology company with products backed by a strong domain expertise to provide cost-effective comprehensive solutions for businesses. "
target: Applied Clinical Intelligence
Applied Clinical Intelligence was founded in 2001 to provide data-driven solutions for clinical trials and risk management programs. ACI is a specialized clinical services group offering strategic, operational, and technical intelligence.
price ($mm)
$4.71
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/1/2005 via Company Press Release

Thomson Pharma, acquired Pharmaceutical Information Associates, Ltd.

synopsis: The Thomson Corporation announced that it has acquired Pharmaceutical Information Associates Ltd (PIA) and Astrolabe Analytica, Inc. (AAI). PIA and AAI are leading providers of regulatory consulting, marketing analytics and scientific communications services for the pharmaceutical industry.
buyer parent: The Thomson Corporation
buyer: Thomson Pharma
Thomson Pharma is a dynamic, information offering for the pharmaceutical and biotechnology industries that is being developed by Thomson Scientific. "
target: Pharmaceutical Information Associates, Ltd.
Since 1990, Pharmaceutical Information Associates has supported the global drug development process by assisting with regulatory strategy development, the preparation of regulatory documentation, and the design, conduct, and audit of specialized clinical studies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/27/2021 via BNC Analysis

Paine Schwartz Partners, acquired Registrar Corp

synopsis: Paine Schwartz Partners, a private equity firm specializing in sustainable food chain investing, has acquired Registrar Corp from Bertram Capital. Registrar, headquartered in Hampton, VA, is a provider of U.S. Food and Drug Administration compliance software and services to food, medical device, drug, and cosmetic facilities all over the world.
buyer: Paine Schwartz Partners
A global leader in sustainable food chain investing, Paine Schwartz Partners is a private equity firm focused exclusively on investment opportunities in the fast-growing, dynamic global food and agribusiness sectors. "
target parent: Bertram Capital Management LLC
target: Registrar Corp
Registrar Corp is a leading SaaS assisted provider of U.S. Food and Drug Administration (“FDA”) compliance services to domestic and foreign food, medical device, drugs, and cosmetic facilities. Registrar Corp was founded in 2003 and has headquarters in Hampton, Virginia, USA.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/2/2020 via Company Press Release

Cytel Inc., acquired Laiya Consulting, Inc.

synopsis: Cytel Inc. has announced the acquisition of Laiya Consulting, a drug development solutions company specializing in Bayesian adaptive trial designs and implementation. Laiya pioneered the delivery of trial design software using SaaS, which aligns with Cytel’s goal of making all of its design software available as a cloud-based service.
buyer parent: New Mountain Capital, LLC
buyer: Cytel Inc.
Cytel provides statistical software for clinical trials. Cytel provides an understanding of software tools that solve statistical problems and that meet the highest standards of reliability, technical documentation and customer support. "
target: Laiya Consulting, Inc.
Founded in 2010, Laiya Consulting has supported drug developers to drive success rates and maximize portfolio returns through the design and implementation of Bayesian adaptive trials, robust clinical strategies, and integrated software platforms.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/6/2019 via Company Press Release

Advarra, acquired Kinetiq

synopsis: Advarra, the premier provider of institutional review board (IRB) and research quality and compliance consulting services, acquired Quorum’s research and technology consulting division, Kinetiq. Kinetiq delivers innovative solutions for human subject protection and compliance in clinical research.
buyer parent: Linden Capital Partners
buyer: Advarra
Advarra, headquartered in Columbia, Md., provides institutional review board (IRB), institutional biosafety committee (IBC) and global research compliance services to clinical trial sponsors, CROs, hospital systems, academic medical centers and investigators. "
target parent: Quorum Review IRB
target: Kinetiq
Kinetiq is a consulting and technology division of Quorum Review IRB that delivers innovative solutions for human subject protection and compliance in clinical research.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/23/2019 via Company Press Release

21 Partners, acquired ProductLife Group

synopsis: 21 Invest France has acquired ProductLife Group.ProductLife Group is an expert in regulatory affairs outsourced management and pharmacovigilance for the Healthcare and Life Sciences industries and more specifically for pharmaceutical laboratories.
buyer: 21 Partners
European-based 21 Partners uses reasonable efforts to obtain information from sources which it believes to be reliable, no representation or warranty is given that the information or opinions contained in this website are accurate, reliable or complete. "
target: ProductLife Group
Based in France, ProductLife Group is the global leader in regulatory and safety services, consulting, and outsourcing solutions for the life sciences industry. ProductLife Group is built on a unique and functional platform-and-geographic-hub model.
price ($mm)
rev ($mm)
$28
EBITDA ($mm)
EV / rev
0.0x
EV / EBITDA
closed 12/21/2018 via BusinessWire

GHO Capital, acquired Validant

synopsis: GHO Capital, the European specialist investor in healthcare, has acquired a majority stake in Validant. Validant provides specialist consulting services, with a focus on quality, compliance and regulatory affairs, to a broad range of clients across the biotech, pharma and medtech sectors.
buyer: GHO Capital
Global Healthcare Opportunities, or GHO Capital Partners LLP, is a leading specialist healthcare investment advisor based in London. They apply global capabilities and perspectives to unlock high growth healthcare opportunities in Europe, building market leading businesses of strategic global value."
target: Validant
Operating globally with offices in Europe and North America, Validant provides specialist consulting services, with a focus on quality, compliance and regulatory affairs, to a broad range of clients across the biotech, pharma and medtech sectors.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/30/2018 via PR Newswire

Premier Research Group, acquired Regulatory Professionals, Inc.

synopsis: Premier Research, a global provider of clinical development services to biopharmaceutical product innovators, has acquired Regulatory Professionals, Inc. (RPI), a California-based company that provides regulatory expertise and solutions to biotechnology, pharmaceutical, and medical device companies.
buyer parent: ECI Partners
buyer: Premier Research Group
Premier Research is a leading clinical development service provider that helps biotech and specialty pharma innovators — small companies with big ambitions — transform life-changing ideas into new medicines. "
target: Regulatory Professionals, Inc.
Regulatory Professionals, Inc. (RPI) provides strategic advice, regulatory planning, and a full range of submission services, helping its clients advance the development and registration of their products in worldwide markets.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/13/2018 via Company Press Release

Bertram Capital Management LLC, acquired Registrar Corp

synopsis: Bertram Capital announced its investment in Registrar, LLC, a leading SaaS assisted provider of U.S. Food and Drug Administration (“FDA”) compliance services to domestic and foreign food, medical device, drugs, and cosmetic facilities.
buyer: Bertram Capital Management LLC
Bertram Capital is a private equity firm targeting investments in lower middle market companies. By supplying flexible investment capital and committing a wealth of operational and strategic resources, they make their core objective to move companies toward unlocking their full potential. "
target: Registrar Corp
Registrar Corp is a leading SaaS assisted provider of U.S. Food and Drug Administration (“FDA”) compliance services to domestic and foreign food, medical device, drugs, and cosmetic facilities.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/3/2016 via Company Press Release

Linden Capital Partners, acquired ProPharma Group

synopsis: Linden Capital Partners, a Chicago-based healthcare private equity firm, announced that it has completed its acquisition of ProPharma Group. ProPharma Group is a leading provider of outsourced medical information, pharmacovigilance, and compliance consulting services to customers in the pharmaceutical, biotechnology and medical device industries.
buyer: Linden Capital Partners
Linden Capital Partners is a Chicago-based private equity firm focused exclusively on leveraged buyouts in the healthcare and life sciences industries. "
target: ProPharma Group
ProPharma Group is a leading provider of outsourced medical information, pharmacovigilance, and compliance consulting services to customers in the pharmaceutical, biotechnology and medical device industries.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/26/2012 via BusinessWire

Accenture, acquired Octagon Research Solutions, Inc.

synopsis: Accenture completed its acquisition of Octagon Research Solutions, a provider of clinical and regulatory information management solutions and software for the pharmaceutical industry. The acquisition enhances Accenture's existing clinical services capabilities – including clinical data management, clinical programming and safety case processing.
buyer: Accenture (ACN:$53,736.36)
Accenture is a global management consulting, technology services and outsourcing company. Accenture collaborates with clients to help them become high performance businesses and governments. "
target parent: Edison Ventures
target: Octagon Research Solutions, Inc.
Octagon Research Solutions is the world leader in clinical and regulatory information management solutions to the life sciences industry. Through an integrated suite of outsourced services, strategic consulting, and innovative technology, Octagon optimizes the entire drug development lifecycle.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 7/18/2012 via BusinessWire

Adjility Health will be merged with Alliance Life Sciences Consulting Group, Inc,

synopsis: Alliance Life Sciences Consulting Group (ALSCG), a leading management and technology consultancy, and Adjility Consulting, a consulting firm specializing in management consulting and analytic solutions for clinical operations and the global market access, pricing and reimbursement space, announced that the two companies will merge.
buyer: Alliance Life Sciences Consulting Group, Inc
Alliance Life Sciences Consulting Group employs more than 175 professionals who collectively understand the business challenges of the Life Sciences industry and offer solutions for Sales & Marketing, Managed Care & Government Contracting, Commercial Operations, Information Management and Analytics."
target: Adjility Health
Adjility Health is dedicated to helping healthcare companies improve their operations through the use of strategic consulting services and very industry domain-specific analytic, forecasting, predictive trending and other data insight tools.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/3/2012 via BusinessWire

Dohmen Company, acquired BioSoteria, Inc.

synopsis: The Dohmen Company has acquired BioSoteria, a leading provider of drug safety and risk management services to the biopharmaceutical industry. The BioSoteria management team has experience building drug safety departments from the ground up at start-up companies and expanding pharmacovigilance capabilities for larger companies.
buyer: Dohmen Company
Dohmen is a provider of outsourced business services. Dohmen’s portfolio of service offerings includes outsourced business services to life science manufacturers through DDN, and benefit management services to life science payers through RESTAT. "
target: BioSoteria, Inc.
BioSoteria provides a broad range of drug safety services to the biopharmaceutical industry. BioSoteria helps companies manage the safety of their products with a regulatory-compliant, best-practices approach. Being a trusted pharmacovigilance service provider begins with leadership.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/6/2019 via PE Hub

Catalyst Clinical Research, LLC, acquired Tri Stat

synopsis: Catalyst Clinical Research, LLC, a leading provider of clinical operation solutions to the biotechnology, pharmaceutical and medical device companies, has acquired Triangle Biostatistics, LLC (Tri Stat), a leading provider of statistical programming, statistical consulting, and data management services for the pharmaceutical industry.
buyer parent: NovaQuest
buyer: Catalyst Clinical Research, LLC
Catalyst Clinical Research is a leading provider of clinical operation solutions to the biotechnology, pharmaceutical and medical device companies. The company assists clients with their clinical development programs by providing therapeutically-aligned experts and teams and customized solutions. "
target: Tri Stat
Triangle Biostatistics (Tri Stat) is a leading provider of statistical programming, statistical consulting, and data management services for the pharmaceutical industry. Tri Stat provides strong statistical consulting and programming support utilizing the latest computing technology.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA

Like Cornerstone Research Group


read more

Cornerstone Research Group

Redwood Outcomes

Oxford Outcomes

Minter Group

Elysia Group

Double Helix

Rood Research, Inc.

Verispan, LLC

HAYES, Inc.

MetaWorks, Inc.

Pharmerit International

xsperient

Medical Collective Intelligence Co. Ltd.

WWMR, Inc.

Best Doctors, Inc.

Kantar Health

Manthan Systems

SDI Health LLC

EMS Research

3ES

read more

Cornerstone Research Group

read more

Intouch Group, LLC

Alkemy Partners LLC

HVH Precision Analytics

Cornerstone Research Group

read more

Covex, LLC

ACI Clinical

Synchrogenix Information Strategies, Inc.

Behavioral Health Care Associates, Ltd.

CFS Clinical

Polaris Biopharma Consulting

Applied Clinical Intelligence

Pharmaceutical Information Associates, Ltd.

Registrar Corp

Laiya Consulting, Inc.

Kinetiq

ProductLife Group

Validant

Regulatory Professionals, Inc.

Registrar Corp

ProPharma Group

Octagon Research Solutions, Inc.

Adjility Health

BioSoteria, Inc.

Tri Stat

Geography
Matching Companies
Ticker:
 
 
 
 
 
 
 
 
Clarivate plc
Clarivate plc
Clarivate is a global leader in providing solutions to accelerate the lifecycle of innovation. Clarivate helps customers discover, protect and commercialize their inventions using its trusted subscription and technology-based solutions coupled with deep domain expertise.
year
2021
rev ($mm)
$1,614.03
EBITDA ($mm)
$542.18
EBIT ($mm)
$84.79
Net Income ($mm)
Employees
8568
  • drill down
  • watch
Ticker: NYSE:IQV
 
 
 
 
 
 
 
 
IQVIA
IQVIA
IQVIA Holdings Inc. provides integrated information and technology-enabled healthcare services in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Commercial Solutions, Research & Development Solutions, and Integrated Engagement Services.
year
2018
rev ($mm)
$10,412.00
EBITDA ($mm)
$1,950.00
EBIT ($mm)
$809.00
Net Income ($mm)
$259.00
Employees
58000
  • drill down
  • watch
Ticker: WX
 
 
 
 
 
 
 
 
WuXi AppTec
WuXi AppTec
WuXi AppTec is a leading global pharmaceutical, biopharmaceutical, and medical device open-access capability and technology platform with operations in China and the United States. WuXi AppTec provides a broad and integrated portfolio of services throughout the drug R&D process.
year
2014
rev ($mm)
$640.80
EBITDA ($mm)
$155.57
EBIT ($mm)
$108.53
Net Income ($mm)
$112.01
Employees
7445
  • drill down
  • watch
Ticker: AIM:C4XD
 
 
 
 
 
 
 
 
C4X Discovery
C4X Discovery aims to become the world’s most productive drug discovery and development company by exploiting cutting-edge technologies to design and create best-in-class drug candidates.
year
2015
rev ($mm)
$0.44
EBITDA ($mm)
($5.46)
EBIT ($mm)
($5.50)
Net Income ($mm)
Employees
19
  • drill down
  • watch
Ticker: BSE:532890
 
 
 
 
 
 
 
 
TAKE Solutions, Inc.
TAKE Solutions, Inc.
TAKE Solutions delivers domain-intensive services in Life Sciences and Supply Chain Management. Their range of services span from clinical trials to regulatory submissions to post-marketing safety, all backed by insights derived through proprietary industry networks forums.
year
2018
rev ($mm)
$259.76
EBITDA ($mm)
$39.17
EBIT ($mm)
$33.43
Net Income ($mm)
$28.24
Employees
1500
  • drill down
  • watch
Ticker: PBSV
 
 
 
 
 
 
 
 
Pharma-Bio Serv Inc.
PharmaBio Serv offers a full range of Regulatory Compliance Quality Systems, Validation & Qualification Services and Technology Transfer based on the latest FDA guidelines, as well as day to day process support.
year
2008
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: XTRA:EVT
 
 
 
 
 
 
 
 
Evotec BioSystems GmbH
Founded in Hamburg Germany, Evotec BioSystems GmbH is a drug discovery alliance and development partnership company focused on rapidly progressing innovative product approaches with leading pharmaceutical and biotechnology companies, academics, patient advocacy groups and venture capitalists.
year
2017
rev ($mm)
$226.46
EBITDA ($mm)
$53.38
EBIT ($mm)
$38.55
Net Income ($mm)
$40.69
Employees
1316
  • drill down
  • watch
Ticker: INCR
 
 
 
 
 
 
 
 
Syneos Health
Syneos Health
Syneos Health is the only fully integrated biopharmaceutical solutions organization. Their company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities.
year
2021
rev ($mm)
$4,730.38
EBITDA ($mm)
$633.74
EBIT ($mm)
$407.86
Net Income ($mm)
$235.93
Employees
24310
  • drill down
  • watch
Ticker: ICLR
 
 
 
 
 
 
 
 
ICON Plc
ICON Plc
ICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company specialises in the strategic development, management and analysis of programs that support clinical development.
year
2015
rev ($mm)
$1,541.91
EBITDA ($mm)
$289.74
EBIT ($mm)
$234.82
Net Income ($mm)
$192.14
Employees
11200
  • drill down
  • watch
Ticker:
 
 
 
 
 
 
 
 
CMIC Co., Ltd.
CMIC is a leading full-service CRO in Japan offering a wide range of services in clinical trials in Asia to both multi-national and Japanese pharma companies.
year
2019
rev ($mm)
$664.65
EBITDA ($mm)
$76.21
EBIT ($mm)
$43.15
Net Income ($mm)
$23.12
Employees
4962
  • drill down
  • watch
Ticker: PIELF
 
 
 
 
 
 
 
 
Pierrel SpA
Pierrel SpA
Pierrel S.p.A. is a pharmaceutical company specializing in contract research, development and the manufacture of medicines. The Pierrel Group boasts over 50 years of experience in the pharmaceutical sector, and is one of the main Italian manufacturers of local anaesthetics for dental use.
year
2008
rev ($mm)
$64.38
EBITDA ($mm)
($4.23)
EBIT ($mm)
($8.92)
Net Income ($mm)
Employees
504
  • drill down
  • watch
Ticker: ENCO
 
 
 
 
 
 
 
 
Encorium Group Inc.
Encorium is a full-service Contract Research Organization providing comprehensive solutions for pharmaceutical, biotechnology, and medical device companies. At Encorium we recognize the challenges that often arise during drug development.
year
2008
rev ($mm)
$35.91
EBITDA ($mm)
($5.19)
EBIT ($mm)
($6.89)
Net Income ($mm)
Employees
226
  • drill down
  • watch
Ticker: EMED
 
 
 
 
 
 
 
 
MedCom USA, Inc.
MedCom USA, Inc. (EMED) provides innovative healthcare and financial transaction solutions for electronically processing HIPAA compliant transactions within the healthcare industry.
year
2008
rev ($mm)
$2.90
EBITDA ($mm)
($0.40)
EBIT ($mm)
($0.62)
Net Income ($mm)
Employees
13
  • drill down
  • watch
Ticker: MCK
 
 
 
 
 
 
 
 
McKesson Corporation
McKesson Corporation
McKesson Corporation is a healthcare services and information technology company dedicated to making the business of healthcare run better. McKesson partners with payers, hospitals, physician offices, pharmacies, pharmaceutical companies and others across the spectrum of care.
year
2019
rev ($mm)
$214,319.00
EBITDA ($mm)
$4,229.00
EBIT ($mm)
$3,280.00
Net Income ($mm)
$34.00
Employees
70000
  • drill down
  • watch
Ticker: TSXV:IPA
 
 
 
 
 
 
 
 
ImmunoPrecise
ImmunoPrecise
ImmunoPrecise Antibodies (IPA) is a full-service, therapeutic antibody discovery company offering species agnostic advancements such as the B cell Select™ single-cell interrogation technology, DeepDisplay™ custom phage libraries, as well as the Abthena™.
year
2021
rev ($mm)
$14.38
EBITDA ($mm)
($3.69)
EBIT ($mm)
($5.34)
Net Income ($mm)
Employees
73
  • drill down
  • watch
Ticker: CRL
 
 
 
 
 
 
 
 
Charles River Laboratories International Inc.
Charles River Laboratories International Inc.
Charles River has been helping our global partners accelerate drug discovery and development by providing them with tailored research models and preclinical, clinical, support services.
year
2009
rev ($mm)
$1,202.55
EBITDA ($mm)
$282.48
EBIT ($mm)
$188.93
Net Income ($mm)
$114.44
Employees
8000
  • drill down
  • watch
Ticker: ENXTPA:ERF
 
 
 
 
 
 
 
 
Eurofins Group
Eurofins Group
Based in Luxembourg, Eurofins is a leading international group of laboratories providing a unique range of analytical testing services to the pharmaceutical, food, environmental and consumer products industries and to governments.
year
2019
rev ($mm)
$5,244.00
EBITDA ($mm)
$922.65
EBIT ($mm)
$524.54
Net Income ($mm)
$224.34
Employees
47427
  • drill down
  • watch